Lactoferrin exhibits PEDV antiviral activity by interfering with spike-heparan sulfate proteoglycans binding and activating mucosal immune response

Abstract Neonatal piglets infected with Porcine Epidemic Diarrhea Virus (PEDV) experience a mortality rate of up to 90%, resulting in significant economic losses to the swine industry in China. Current strategies using specific antibodies in sow milk to prevent Porcine Epidemic Diarrhea (PED) in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Peng Liu, Jinjiao Zuo, Hui Lu, Bin Zhang, Caihong Wu
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Veterinary Research
Subjects:
Online Access:https://doi.org/10.1186/s13567-025-01456-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571429774688256
author Peng Liu
Jinjiao Zuo
Hui Lu
Bin Zhang
Caihong Wu
author_facet Peng Liu
Jinjiao Zuo
Hui Lu
Bin Zhang
Caihong Wu
author_sort Peng Liu
collection DOAJ
description Abstract Neonatal piglets infected with Porcine Epidemic Diarrhea Virus (PEDV) experience a mortality rate of up to 90%, resulting in significant economic losses to the swine industry in China. Current strategies using specific antibodies in sow milk to prevent Porcine Epidemic Diarrhea (PED) in these piglets through specific antibodies in sow milk is unsatisfactory. Preliminary studies have shown limited success. Emerging evidence suggests that general immune factors in sow milk provide protection to neonatal piglets, particularly, lactoferrin, play a crucial role in protecting piglets by inhibiting PEDV replication. However, the precise mechanism by which lactoferrin exerts its antiviral effects remains unclear. This study sought to clarify these mechanisms through both in vitro and in vivo approaches, proposing that higher concentrations of lactoferrin lead to greater antiviral activity. It was hypothesized that lactoferrin can impede PEDV by blocking its binding to heparan sulfate proteoglycans (HSPG) on the surface of target cells, and molecular docking experiments was conducted to identify the binding sites between lactoferrin and HSPG. Additionally, the findings indicated that lactoferrin can effectively trigger the maturation of porcine dendritic cells and boosts their antigen-presenting functions, thereby improving intestinal mucosal immunity in neonatal piglets against PEDV. Overall, these findings aid to elucidate the antiviral actions and mechanisms of lactoferrin in sow colostrum, offering new insights for the effective prevention and control of PED in neonatal piglets.
format Article
id doaj-art-27eabf02a1894a0a9980fca9b217eb24
institution Kabale University
issn 1297-9716
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Veterinary Research
spelling doaj-art-27eabf02a1894a0a9980fca9b217eb242025-02-02T12:37:04ZengBMCVeterinary Research1297-97162025-01-0156111410.1186/s13567-025-01456-5Lactoferrin exhibits PEDV antiviral activity by interfering with spike-heparan sulfate proteoglycans binding and activating mucosal immune responsePeng Liu0Jinjiao Zuo1Hui Lu2Bin Zhang3Caihong Wu4College of Veterinary Medicine, Jiangsu Agri-Animal Husbandry Vocational CollegePet Science and Technology College, Jiangsu Agri-Animal Husbandry Vocational CollegeCollege of Veterinary Medicine, Jiangsu Agri-Animal Husbandry Vocational CollegePet Science and Technology College, Jiangsu Agri-Animal Husbandry Vocational CollegeCollege of Veterinary Medicine, Jiangsu Agri-Animal Husbandry Vocational CollegeAbstract Neonatal piglets infected with Porcine Epidemic Diarrhea Virus (PEDV) experience a mortality rate of up to 90%, resulting in significant economic losses to the swine industry in China. Current strategies using specific antibodies in sow milk to prevent Porcine Epidemic Diarrhea (PED) in these piglets through specific antibodies in sow milk is unsatisfactory. Preliminary studies have shown limited success. Emerging evidence suggests that general immune factors in sow milk provide protection to neonatal piglets, particularly, lactoferrin, play a crucial role in protecting piglets by inhibiting PEDV replication. However, the precise mechanism by which lactoferrin exerts its antiviral effects remains unclear. This study sought to clarify these mechanisms through both in vitro and in vivo approaches, proposing that higher concentrations of lactoferrin lead to greater antiviral activity. It was hypothesized that lactoferrin can impede PEDV by blocking its binding to heparan sulfate proteoglycans (HSPG) on the surface of target cells, and molecular docking experiments was conducted to identify the binding sites between lactoferrin and HSPG. Additionally, the findings indicated that lactoferrin can effectively trigger the maturation of porcine dendritic cells and boosts their antigen-presenting functions, thereby improving intestinal mucosal immunity in neonatal piglets against PEDV. Overall, these findings aid to elucidate the antiviral actions and mechanisms of lactoferrin in sow colostrum, offering new insights for the effective prevention and control of PED in neonatal piglets.https://doi.org/10.1186/s13567-025-01456-5LactoferrinPEDVheparan sulfate proteoglycansmucosal immunityneonatal piglets
spellingShingle Peng Liu
Jinjiao Zuo
Hui Lu
Bin Zhang
Caihong Wu
Lactoferrin exhibits PEDV antiviral activity by interfering with spike-heparan sulfate proteoglycans binding and activating mucosal immune response
Veterinary Research
Lactoferrin
PEDV
heparan sulfate proteoglycans
mucosal immunity
neonatal piglets
title Lactoferrin exhibits PEDV antiviral activity by interfering with spike-heparan sulfate proteoglycans binding and activating mucosal immune response
title_full Lactoferrin exhibits PEDV antiviral activity by interfering with spike-heparan sulfate proteoglycans binding and activating mucosal immune response
title_fullStr Lactoferrin exhibits PEDV antiviral activity by interfering with spike-heparan sulfate proteoglycans binding and activating mucosal immune response
title_full_unstemmed Lactoferrin exhibits PEDV antiviral activity by interfering with spike-heparan sulfate proteoglycans binding and activating mucosal immune response
title_short Lactoferrin exhibits PEDV antiviral activity by interfering with spike-heparan sulfate proteoglycans binding and activating mucosal immune response
title_sort lactoferrin exhibits pedv antiviral activity by interfering with spike heparan sulfate proteoglycans binding and activating mucosal immune response
topic Lactoferrin
PEDV
heparan sulfate proteoglycans
mucosal immunity
neonatal piglets
url https://doi.org/10.1186/s13567-025-01456-5
work_keys_str_mv AT pengliu lactoferrinexhibitspedvantiviralactivitybyinterferingwithspikeheparansulfateproteoglycansbindingandactivatingmucosalimmuneresponse
AT jinjiaozuo lactoferrinexhibitspedvantiviralactivitybyinterferingwithspikeheparansulfateproteoglycansbindingandactivatingmucosalimmuneresponse
AT huilu lactoferrinexhibitspedvantiviralactivitybyinterferingwithspikeheparansulfateproteoglycansbindingandactivatingmucosalimmuneresponse
AT binzhang lactoferrinexhibitspedvantiviralactivitybyinterferingwithspikeheparansulfateproteoglycansbindingandactivatingmucosalimmuneresponse
AT caihongwu lactoferrinexhibitspedvantiviralactivitybyinterferingwithspikeheparansulfateproteoglycansbindingandactivatingmucosalimmuneresponse